Sweden· SE-20220225000034
Daforbis 5 mg Filmdragerad tablett
A medicinal product containing dapagliflozin, registered in Sweden by Viatris Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Dapagliflozin
- Manufacturer
- Viatris Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20220225000034
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dapagliflozin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDAPAGLIFLOZIN AVIANTAAvianta Pharma EU Limited, Dublin
- United StatesDapagliflozinSandoz Inc
- PolandDaforbisViatris Ltd
- SpainDAFORBIS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGViatris Limited
- NetherlandsDapagliflozine Accord 5 mg filmomhulde tablettenAccord Healthcare B.V.
- SwitzerlandDapagliflozin Devatis 5 mg, FilmtablettenDevatis AG
- IcelandDapagliflozin KrkaKrka, d.d., Novo mesto
- IrelandDapagliflozin MSN 5 mg film-coated tabletsMSN Labs Europe Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dapagliflozin +pharma, Dapagliflozin Devatis
- Belgium · Dapagliflozin Ab, Dapagliflozin Eg
- Bulgaria · Dapagliflozin Sandoz, Dapagliflozin Tchaikapharma
- Cyprus · Daforbis, Dapagliflozin Farmoz
- Czechia · Dagetia, Dagrafors
- Germany · Daglin, Dapagliflozin 123-Acurae Pharma
- Denmark · Dapagliflozin, Dapagliflozin "sandoz"
- Estonia · Dagrafors, Dapagliflozin Alembic
- Spain · Daforbis, Dapagliflozina Aurovitas
- Finland · Dapagliflozin Devatis, Dapagliflozin Krka
- France · Dapagliflozine Arrow, Dapagliflozine Biogaran
- United Kingdom (Northern Ireland) · Daforbis, Dapagliflozin
- Greece · Brolertix, Daforbis
- Croatia · Daforbis, Dagrafors
- Hungary · Dagrafors, Dapagliflozin Sandoz
- Ireland · Dapagliflozin Clonmel, Dapagliflozin Krka
- Iceland · Dapagliflozin Krka, Dapagliflozin Krka D.D.
- Italy · Dapagliflozin Aurobindo, Dapagliflozin Doc
- Liechtenstein · Dapagliflozin Viatris, Edistride
- Lithuania · Dagrafors, Dapagliflozin Accord
- Luxembourg · Dapagliflozin Eg
- Latvia · Daglin, Dagrafors
- Malta · Dapagliflozin Ascend, Dapagliflozin Aurobindo
- Netherlands · Dapagliflozin Alembic, Dapagliflozin Amarox
- Norway · Dapagliflozin Alembic, Dapagliflozin Devatis
- Poland · Daforbis, Dagrafors
- Portugal · Dalzior, Dapagliflozin Ipca
- Romania · Daforbis, Dagetia
- Slovenia · Dagrafors, Dapagliflozin Hcs
- Slovakia · Dagetia, Dagrafors
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/24d13c42-b6a1-4358-8ad0-e5070ab00bd5 GET /v1/drugs/24d13c42-b6a1-4358-8ad0-e5070ab00bd5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR",
"sPAR",
"SmPC",
"PL"
],
"se_npl_id": "20220225000034",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20220225000034",
"product_doc_link": "https://docetp.mpa.se/LMF/Daforbis%20film-coated%20tablet%20ENG%20SmPC_09001bee83698845.pdf"
}See everything about dapagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.